Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164164 · ClinicalTrials.gov registry record · Phase 3
HalfLytely Bowel Prep System for Colonoscopy
A Phase 3 study of Colonoscopy, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT00164164 is a Phase 3 study of Colonoscopy that has completed, run by Braintree Laboratories. The registered enrollment target is 200 participants, below the 492-participant average among 20 other Colonoscopy trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00164164, a Phase 3 study of Colonoscopy, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the this study was to compare the safety and efficacy of HalfLytely (2L NULYTELY + 20mg bisacodyl) to NULYTELY for preparation prior to colonoscopy.
Conditions Studied
Interventions
- DRUG HalfLytely
- DRUG NuLytely
Study Locations (2)
Massachusetts
- - Braintree
Texas
- - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1999-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164164
The ClinicalTrials.gov registry entry for NCT00164164 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 492-participant average among 20 other Colonoscopy trials with a reported enrollment target (59% lower). The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colonoscopy appearing as the primary indexed condition, and to 2 interventions - of which HalfLytely is the first listed.
NCT00164164 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Texas.
Frequently Asked Questions
What is clinical trial NCT00164164 about?
NCT00164164 is a clinical study titled "HalfLytely Bowel Prep System for Colonoscopy". The purpose of the this study was to compare the safety and efficacy of HalfLytely (2L NULYTELY + 20mg bisacodyl) to NULYTELY for preparation prior to colonoscopy.
What is the current status of trial NCT00164164?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 1999-08.
What conditions does trial NCT00164164 study?
This clinical trial studies the following conditions: Colonoscopy.
What interventions are being tested in trial NCT00164164?
The interventions under investigation include: HalfLytely (DRUG), NuLytely (DRUG).
Who is sponsoring clinical trial NCT00164164?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00164164 being conducted?
This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
-
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
COMPLETED · Phase 3
-
BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
COMPLETED · Phase 3
-
A Safety Study of 3 Different Bowel Cleansing Preparations
COMPLETED · Phase 3
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.